The text starts here.

News Release

Information in the news releases is current on the date of the announcement, but is subject to change without prior notice.

1997 Release

December 18, 1997 Notice of Subsidiary Merger
December 15, 1997 Eisai Launches PARIET (sodium rabeprazole), A New Proton Pump Inhibitor for Peptic Ulcers in Japan
November 7, 1997 Eisai Announces Completion of US Pharmaceutical Formulation Research and Manufacturing Facility
November 4, 1997 Eisai Announces Non-Consolidated Semiannual Financial Results for the Fiscal Year Ending March 31, 1998
September 20, 1997 Eisai Announces Launch of Consumer Health Information on Corporate Home Page
September 16, 1997 Eisai Announces Launch of ARICEPT(R) (donepezil hydrochloride), NewTreatment For Alzheimer's Disease in Germany
September 4, 1997 "KURTIME-MK", a Medicated Bath Additive Beneficial For Numerous Skin Disorders Including Eczema Launched By Eisai
August 25, 1997 "SAHNE LIP", a Lip Balm For the Prevention of Dryness Launched By Eisai
August 22, 1997 Eisai Establishes KAN Research Institute
July 28, 1997 Eisai Establishes Operations in Korea
July 15, 1997 Eisai's Alzheimer's Treatment Receives Agreement For Approval In 12 European Countries
June 11, 1997 Eisai Machinery Division Receives ISO 9001 Certification
June 3, 1997 Eisai Announces Ground Breaking For Pharmaceutical Production Facility in Suzhou, China
May 27, 1997 Eisai Announces Non-Consolidated and Consolidated Financial Results for the Fiscal Year Ended March 31, 1997
April 15, 1997 Eisai and Janssen Pharmaceutica Announce Strategic Alliance For New Proton Pump Inhibitor
April 14, 1997 Eisai Announces Completion of US Process Research Facility
April 7, 1997 Eisai Launches ARICEPT(TM) (donepezil hydrochloride), New Treatment For Alzheimer's Disease in the UK
March 5, 1997 Eisai's New Alzheimer's Disease Treatment Was Filed In Mexico By Wyeth-Ayerst
February 26, 1997 Notice of Dividend Payment for the Year Ending March 1997 (85th Fiscal Term)
February 27, 1997 Eisai Launches ARICEPT(TM) (donepezil hydrochloride), New Treatment For Alzheimer's Disease In the US
February 26, 1997 Eisai Receives Marketing Clearance In UK For ARICEPT(TM)(donepezil hydrochloride), A New Symptomatic Treatment For Alzheimer's Disease
January 22, 1997 Eisai Submits Marketing Authorization Application (MAA) in U.K. for a New Proton Pump Inhibitor

Back to Top